|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
This excerpt taken from the ELN 20-F filed Feb 28, 2008. Tysabri-United
States
In the U.S. market, we recorded net sales of
$217.4 million (2006: $28.2 million; 2005:
$11.0 million). As of the end of December 2007, more than
2,500 doctors have enrolled patients and approximately
12,900 patients were on commercial Tysabri therapy.
|
| |||||||